Commonwealth of Pennsylvania Public School Employees Retirement System’s BioMarin Pharmaceuticals BMRN Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Sell	46,273 -1,862	-4%	-$102K	0.01%	749
2026 Q1	$2.72M	Buy	48,135 +60	+0.1%	+$3.5K	0.01%	704
2025 Q4	$2.86M	Sell	48,075 -1,205	-2%	-$65.6K	0.01%	691
2025 Q3	$2.67M	Buy	49,280 +7	+0%	+$400	0.01%	700
2025 Q2	$2.71M	Buy	49,273 +3,716	+8%	+$219K	0.01%	661
2025 Q1	$3.22M	Buy	45,557 +3,466	+8%	+$233K	0.02%	565
2024 Q4	$2.77M	Buy	42,091 +124	+0.3%	+$8.31K	0.02%	605
2024 Q3	$2.95M	Sell	41,967 -119	-0.3%	-$9.95K	0.02%	581
2024 Q2	$3.46M	Buy	+42,086	New	+$3.5M	0.02%	494

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's BMRN Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System reduced its BioMarin Pharmaceuticals (BMRN) stake by 3.9% in Q2 2026, selling an estimated $102K and leaving 46,273 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #749.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in BMRN in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.46M in Q2 2024. 351 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Commonwealth of Pennsylvania Public School Employees Retirement System held 46,273 shares of BioMarin Pharmaceuticals worth $2.65M as of Q2 2026.
Commonwealth of Pennsylvania Public School Employees Retirement System sold 1,862 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $102K.
BioMarin Pharmaceuticals made up 0.01% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #749 holding.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Commonwealth of Pennsylvania Public School Employees Retirement System's BioMarin Pharmaceuticals position peaked at $3.46M in Q2 2024.
351 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.